TCR clonotype analysis demonstrates immune response to Mycobacterium tuberculosis in memory CD4+ T cells, suggesting new TB vaccine implications.
Description CD4+ T cell responses to Mycobacterium tuberculosis (Mtb) antigens processed and presented by infected macrophages leads to control of infection. However, not all T cells specific for Mtb antigens recognize infected macrophages. Using ex vivo co-culture of primary human T cells obtained from healthy individuals with latent Mtb infection (LTBI) together with autologous macrophages infected with Mtb, we estimate that >80% of memory CD4+ T cells recognize Mtb-infected macrophages. Using TCR sequencing and GLIPH2 grouping of activated CD4+ T cells, we identified “likely” and “known” Mtb antigen-specific TCR clonotypes based on previous TCR annotation. While 70-80% of unique and >90% of total TCR clonotypes found in circulation were linked to recognition of infected macrophages, a subpopulation 10-20% were not. Using single-cell transcriptomics, TCRs were mapped to function. IFNg, TNF, and lymphotoxin-alpha (LTa) were preferentially expressed only among clusters containing clonally-expanded TCRs. While top GLIPH2 groups mapped to several clusters, those co-expressing IFNg, TNF, LTa, IL-2, and GM-CSF were preferentially enriched for Mtb-specific TCRs. GM-CSF and “polyfunctional” T cells have been shown to play protective roles against Mtb infection. These results link the effector functions of antigen-specific memory CD4+ T cells to recognition of the infected macrophage and stable LTBI. T cell recognition assays would enhance the evaluation and development of new TB vaccines.
No takes yet. Share an insight, caveat, or question.
Stephen M. Carpenter (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: